Stomach cancer stage 2 treatment in Israel — get 3 personalized clinic matches

Prof. Merimsky leads the Soft Tissue and Bone Oncology Unit at Sourasky Medical Center, with decades of specialized experience in stomach cancer.

• Associate Professor of Oncology at Tel-Aviv University
• Fellowship-trained at Institut Gustave Roussy in Paris
• Member of ESMO Sarcoma Faculty and ASCO
• Published extensively on cancer treatment outcomes

Dr. Pelles Sharon specializes in stomach cancer surgery at Sourasky Medical Center (Ichilov), with expertise in advanced treatments like HIPEC and immunotherapy.

• Performs complex stomach cancer surgeries including Whipple procedures
• Pioneers Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for aggressive cases
• Offers immunotherapy options like Keytruda for targeted treatment
• Leads clinical research on oncologic patients' attitudes toward trials

He leads a dedicated Cancer Prevention Center at Tel Aviv's Sourasky Medical Center, focusing on early detection and treatment of GI cancers.

• Over 44 years of experience of specialized experience in gastrointestinal (GI) tract oncology
• Head of the Integrated Cancer Prevention Center – one of Israel's leading cancer facilities
• Author of more than 300 research papers on cancer prevention and gene therapy
• Completed significant research work at NewYork-Presbyterian Center in the USA
• Member of key international societies like the European Society of Digestive Oncology

Dr. Arnon Nagler is an internationally recognized hematologist and bone marrow transplant expert. He is a Professor of Medicine at Tel Aviv University. He is Director Emeritus of Hematology & Bone Marrow Transplantation and the Cord Blood Bank at Sheba Medical Center. He earned his M.D. from the Hebrew University–Hadassah and an M.Sc. in hematopoiesis from Tel Aviv University. He completed postdoctoral training at Stanford. He is board certified in internal medicine and hematology.

He has more than 35 years of experience. He pioneered reduced‑intensity allogeneic transplant protocols for malignant and non‑malignant diseases. He founded Israel’s first public cord blood bank. He performed the country’s first cord blood transplants.

He has held international leadership roles. He served as Chair and Co‑Chair of the ALWP of the EBMT. He was a vice‑chair and long‑term member of EBMT committees. He served on the board of NetCord/EuroCord and as treasurer. He is a frequent invited speaker. He has published widely in journals such as Blood and Leukemia. He has led major clinical trials as a principal investigator and held editorial roles. He has received multiple awards for innovation and clinical excellence.